Evidence & regulatory context
- Mechanism
- Crude ethanolic fruit-pulp extract of Raphia hookeri (African raffia palm); no ChEMBL entity for a multi-component botanical extract. No ClinicalTrials.gov record (searched, not assumed).
- Target
- Not recorded
- Injury models
- TBI
- Reported indication
- Not recorded
- First approval
- Not recorded
- Development stage
- Not recorded
- ChEMBL record
- Not recorded
- ChEMBL max phase
- Not recorded
- Synonyms
- Not recorded
- Note
- Not recorded
Clinical trials 0
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
No linked human trial in this dataset.
Preclinical evidence 1
1 studies reported at therapy level; 1 evidence entries itemised.
RatTBIWeight-drop / impact-accelerationWistarFemalen = 36 rats in 6 groups of 6Oral gavage100 mg/kgStarted after injury on experimental day 1
Model: Sharp and blunt traumatic brain injury induced by a modified weight-drop technique
Both injury types raised malondialdehyde and reduced glutathione, superoxide dismutase and catalase. Extract administration reduced oxidative damage and lessened subarachnoid and parenchymal haemorrhage in both sharp and blunt injury groups.
Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.7. Machine-extracted fields require source verification.